# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1064501 | B | Inhibition of human P2Y12 receptor expressed in CHO cells | Homo sapiens | 84 | ALA1156904 | cell-based format | Scientific Literature | |
2. | ALA1064502 | F | Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation | Homo sapiens | 84 | ALA1156904 | cell-free format | Scientific Literature | |
3. | ALA1070705 | F | Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation relative to AZD-6140 | Homo sapiens | 78 | ALA1156904 | cell-free format | Scientific Literature | |
4. | ALA1070706 | A | Metabolic stability in rat microsomes | Rattus norvegicus | 84 | ALA1156904 | microsome format | Scientific Literature | |
5. | ALA1070707 | A | Metabolic stability in human microsomes | Homo sapiens | 84 | ALA1156904 | microsome format | Scientific Literature | |
6. | ALA1070708 | A | Clearance in Sprague-Dawley rat at 2 mg/kg, iv and 5 mg/kg, po | Rattus norvegicus | 15 | ALA1156904 | organism-based format | Scientific Literature | |
7. | ALA1070709 | A | Volume of distribution at steady state in Sprague-Dawley rat at 2 mg/kg, iv and 5 mg/kg, po | Rattus norvegicus | 15 | ALA1156904 | organism-based format | Scientific Literature | |
8. | ALA1070710 | A | Effective half life in Sprague-Dawley rat at 2 mg/kg, iv and 5 mg/kg, po | Rattus norvegicus | 15 | ALA1156904 | organism-based format | Scientific Literature | |
9. | ALA1070711 | A | Oral bioavailability in Sprague-Dawley rat at 5 mg/kg, po | Rattus norvegicus | 9 | ALA1156904 | organism-based format | Scientific Literature | |
10. | ALA1070712 | B | Inhibition of human ERG | Homo sapiens | 2 | ALA1156904 | single protein format | Scientific Literature | |
11. | ALA1070713 | T | Toxicity in rat administered as single dose | Rattus norvegicus | 1 | ALA1156904 | organism-based format | Scientific Literature | |
12. | ALA1070715 | P | Solubility at pH 2.0 | 2 | ALA1156904 | small-molecule physicochemical format | Scientific Literature | ||
13. | ALA1070716 | P | Solubility at pH 6.5 | 2 | ALA1156904 | small-molecule physicochemical format | Scientific Literature | ||
14. | ALA1070717 | P | Solubility at pH 9.0 | 2 | ALA1156904 | small-molecule physicochemical format | Scientific Literature | ||
15. | ALA1070718 | A | Protein binding in human plasma assessed as fraction unbound at 0.2 uM | Homo sapiens | 2 | ALA1156904 | cell-free format | Scientific Literature | |
16. | ALA1070719 | A | Protein binding in human plasma assessed as fraction unbound at 2 uM | Homo sapiens | 2 | ALA1156904 | cell-free format | Scientific Literature | |
17. | ALA1070720 | A | Protein binding in human plasma assessed as fraction unbound at 10 uM | Homo sapiens | 2 | ALA1156904 | cell-free format | Scientific Literature | |
18. | ALA1070721 | B | Inhibition of P2Y13 at 10 uM | 1 | ALA1156904 | single protein format | Scientific Literature | ||
19. | ALA1070723 | F | Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by chronolog PRP aggregometry assay | Homo sapiens | 2 | ALA1156904 | cell-free format | Scientific Literature | |
20. | ALA1070724 | B | Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin | Homo sapiens | 2 | ALA1156904 | cell-based format | Scientific Literature |